Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00578656 · ClinicalTrials.gov registry record · Early Phase 1
An Interventional Study of Milk Allergy
A Early Phase 1 study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- Early Phase 1
- Development phase
- 220
- Enrollment target
NCT00578656: Completed Early Phase 1 study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00578656 is a Early Phase 1 study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 220 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (315% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00578656, a Early Phase 1 study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 220 participants
- Enrollment target
Study Summary
Milk is the among the most common food allergens in infants and children. The majority of children outgrow their allergies; however, the exact mechanisms by which food tolerance is achieved are unknown. Strict avoidance of the offending food is currently the only known therapy. However, subjects have been known to lose food hypersensitivity while frequently ingesting small amounts of processed forms of the offending product. The purpose of this study is to investigate whether ingestion of small amounts of processed milk protein will be permitted without compromising the chances of either outgrowing milk hypersensitivity or prolonging the time needed to achieve clinical tolerance.
Interventions
- DIETARY_SUPPLEMENT Baked Milk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2004-06 |
| Est. Completion | 2011-02 |
| Phase | Early Phase 1 |
What the finished NCT00578656 record still lists
NCT00578656 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (315% higher).
The record links to 0 conditions, and to 1 intervention - of which Baked Milk is the first listed.
NCT00578656 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00578656 about?
NCT00578656 is a clinical study titled "An Interventional Study of Milk Allergy". Milk is the among the most common food allergens in infants and children. The majority of children outgrow their allergies; however, the exact mechanisms by which food tolerance is achieved are unknown. Strict avoidance of the offending food is currently the only known therapy. However, subjects hav...
What is the current status of trial NCT00578656?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 220 participants. The study started on 2004-06. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00578656?
The interventions under investigation include: Baked Milk (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00578656?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00578656's enrollment target sits among peer trials
220 54th of 2000 higher than 1,946 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia